New guideline answers important questions about osteoporosis treatment

Postmenopausal osteoporosis is common in men and women over the age of 50. In fact, one in three women and one in five men in this age category are at risk of an osteoporotic fracture, according to the International Osteoporosis Foundation (IOF).

Read More

Is effectiveness of hyaluronans dependent on molecular weight?

Osteoarthritis (OA) is one of the leading causes of disability in the elderly. Changes in the lubricating properties of synovial fluid lead to significant pain and functional disability.

Read More

Getting a grip on gout

Physicians still underestimate the impact of untreated gout and do not view it as a disease that has a severe impact on patients’ quality of life.

Ferrari weighs in on the management of fragility fractures

This article is based on a presentation by Prof Sergei Ferrari, chair of the Council of Scientific Advisors of the International Osteoporosis Foundation (IOF).

Distal radius fractures in the elderly

Osteoporotic fractures are emerging as a major public health problem in the ageing population. Fractures result in increased morbidity, mortality and health expenditures.

Fracture risk prediction, prevention and treatment

SPECIALIST FORUM NOVEMBER CPD 2 of 2: How effective are fracture risk tools? When should treatment be started in patients with osteoporosis? What treatment strategies are recommended and what is the role of supplementation?

Osteoarthritis pain, joint function and QoL

MEDICAL CHRONICLE NOVEMBER CPD 3 of 3: Chronic diseases of the musculoskeletal system are among the most prevalent health hazards in the world’s population.

Prioritising osteoporosis

MEDICAL CHRONICLE SEPTEMBER CPD 1 of 5: Awareness of the consequences of osteoporosis and fragility fractures should be a South African priority.

Efficacy and safety of intra-articular use of hyaluronic acid in the treatment of knee osteoarthritis

MEDICAL CHRONICLE AUGUST CPD 4 of 4: Hyaluronic acid reduces the symptoms and development of osteoarthritis.

Etoricoxib most cost-effective initial NSAID treatment

SPECIALIST FORUM AUGUST CPD 4 of 4: NSAIDs are the mainstay treatment of osteoarthritis and rheumatoid arthritis, two of the leading causes of morbidity and disability worldwide.

Track the crack

SPECIALIST FORUM AUGUST CPD 2 of 4: The increase in fragility fractures worldwide has been described as a ‘silver tsunami’ and is exacerbated by a lack of treatment delivery.